International Bioentrepreneurship Education Conference June 14 - 16, 2013

Manhattan Skyline behind RFK Bridge

Presenter Biographies


Christopher Cullis

Martin Fein

Sheryl Horstman

Brady Huggett

Lynn Johnson Langer

Carol Lin

Thomas Magaldi

William Marshall, JR

Rubin Pillay

Frank Portugal

Brendan Rauw

Randall Ribaudo

Miguel Rojas-Chaves

David Sable

Emily Sheridan

Lidia Sobkow

Nathan Tinker

Finn Valentin

Katherine Wellman

Mitchell Wong


Christopher Cullis

Francis Hobart Herrick Professor and Chair of Biology
Director of the MS Program in Biotechnology Entrepreneurship
Case Western Reserve University, Cleveland, Ohio, USA
Founder and President of NovoMark Technologies Inc.
Degrees awarded
1971      Ph.D., University of East Anglia in Genetics, 1971
1968      M.Sc., University of East Anglia in Biophysics, 1968
1966      B.Sc., (Honors) London University (as external student at the University College of Rhodesia)


Christopher Cullis has been involved in research and education for all his working life. He has held appointments in a number of academic and quasi-academic settings. He has been a research scientist at the John Innes Institute, a faculty member and senior administrator at Case Western Reserve University, and a Program Director of the Plant Genome Research Program at the National Science Foundation (NSF) and is currently chair of the Biology Department. He has also founded and run a Biotechnology Company (NovoMark Technologies Inc). He was elected a Life Fellow of the Ohio Academy of Sciences in 1998 (and a trustee for the Ohio Academy of Sciences in 2008) and to the Board of Directors of The Holden Arboretum in 2004.


Dr Cullis main research interest over more than 40 years and has centered on genomic rearrangements in plant genomes in response to stress. These efforts have resulted in one patent, a successful Biotechnology startup company, in addition to funding form federal, state and commercial sources.


Dr. Cullis is the director and principal architect for the Masters in Biotechnology Entrepreneurship Program at Case Western Reserve University, which has contributed substantially to the economic development of the region.


LinkedIn Profile



Martin Fein, Ph.D. Biophysics back to list

Teaching at Bronx Community College, Department of Biology- 43 years.

Chair of the Department of Biology and Medical Laboratory Technology

Science Division Coordinator (STEM Departments)


Starting a Joint AS/BS Biotechnology Program with CCNY in the Fall2013 Semester



Sheryl Horstman back to list

While still at university, I was privileged to work in multiple laboratories, and in multiple disciplines ranging from a GLOBEC climate change study in the NE Pacific, to the introduction of disease resistant genes to Populus Tomentosa and sterility to diploid and allopolyploid cottons in forestry sciences labs.


Professionally I have been involved in immunological and pharmaceutical studies in several companies and at UW since 1996; predominantly in inflammation and autoimmune disorders, with emphasis in GLP and GCP.


In 2007, I was given the opportunity to switch gears again, and enter into non-traditional adult education at Bates Technical College. This educational program is like nothing I had experienced before, and I have found my passion to be in this field more than any other so far. Working as an educator in a program that I am allowed to develop, has given me all new challenges, and a whole new area of expertise, while still allowing me to follow my first loves, bench work and science.


LinkedIn Profile



Brady Huggett

back to list

Brady received a Bachelor of Science degree in biology from Wake Forest University and a master's in journalism from the University of North Carolina at Chapel Hill. Prior to joining Nature as business editor in 2007, he was managing editor for the suite of products from biotech news service BioWorld, and he has also worked as a staff writer for a university research magazine.



Lynn Johnson Langer

back to list

Lynn Johnson Langer is the Director of Enterprise & Entrepreneurship program, as well as the Regulatory Science Program in the Center for Biotechnology Education at Johns Hopkins University where she is on faculty and heads the Master of Science in Regulatory Science, the MS in Biotechnology/MBA, the MS in Biotechnology Enterprise & Entrepreneurship and Regulatory Science concentration and the Certificate in Biotechnology Enterprise and Entrepreneurship. She brings the merger of science and business to the program. Dr. Langer is on the board of directors of TEDCO, the Maryland Technology Development Corporation. Dr. Langer is on the board of directors and is President emeritus of Women In Bio, an organization of professionals committed to fostering and encouraging entrepreneurship and career development of women active in the life science industry. She attended Tulane University and the University of Maryland for her undergraduate degree in microbiology. She later received her MBA from Johns Hopkins University, and received the Stegman Award for academic excellence in Administrative Science. She received her PhD in Leadership and Change from Antioch University. While a student at Johns Hopkins she co-founded the Hopkins Professional Women’s Network. Dr. Langer has headed the sales and marketing department of several biotechnology companies and worked as a consultant in the bioscience industry. She founded BioPlan Associates, a management and marketing consulting firm. She has worked extensively with leading biomedical and high technology companies. Dr. Langer has been involved in “think-tanks” with organizations such as NASA, developing potential biotechnology products to be tested in space and others in the biomedical field. She has published over fifty articles and several book chapters mainly in business areas of biotechnology and has taught a variety of graduate courses in biotechnology and business. Dr. Langer teaches Leading Change in Biotechnology, Managing and Leading Biotechnology Professionals, Bioscience Communication, Emerging Issues in Biotechnology, Marketing Aspects of Biotechnology and Proseminar in Biotechnology.


LinkedIn Profile



Carol Lin

back to list

Carol Lin directs M.A. and Post Baccalaureate Programs in Biotechnology at Columbia University.  She received her B.S. in Agricultural Chemistry (1981) from National Taiwan University, Ph.D. in Biochemistry (1988) from Case Western Reserve University and M.A. in Higher and Postsecondary Education (2009) from Teachers College, Columbia University.


Carol’s research experience includes postdoctoral training at Massachusetts General Hospital Neurogenetics Lab and research positions as instructor at Tufts University Neuroscience Program, staff scientist at Columbia University College of Physicians and Surgeons Medical Oncology, and assistant professor at York College Natural Sciences, CUNY.  She was a recipient of research grants from National Parkinson Foundation (co-PI) and NIH (RO1 co-PI, AREA PI).


Carol’s teaching experience began when she was awarded tutorship for leading semester-long courses at Harvard University Biology Department while a postdoc.  She has lead courses, workshops and guest lectures for audience ranging from 3rd graders to graduate students.  Since 2000 she has devoted full time to education.


LinkedIn Profile



Thomas Magaldi

back to list

Dr. Thomas Magaldi joins the academy as the new Director of Science Alliance, a consortium of several prominent universities, teaching hospitals and independent research institutions that are dedicated to enhancing the training and education of the next generation of scientists and medical professionals. Dr. Magaldi received his PhD in genetics from Yale University in 2012. During his graduate research, Dr. Magaldi studied viral oncogenes and infectious entry of DNA tumor viruses. Dr. Magaldi then conducted his postdoctoral research at the National Cancer Institute where he helped to discover a new family of viruses not previously known to infect vertebrates.


In addition to working as a molecular virologist, Dr. Magaldi has been involved in both science education and policy throughout his career. He has worked as a tutor and teacher at New Haven Reads, the Center for Science Teaching and Learning and Science Education Outreach Program. Dr. Magaldi has also taught biology as an Adjunct Professor at Montgomery College and Guest Lecturer at the University of the District of Columbia where he learned to use both active learning techniques and interactive technology to engage his students.


Dr. Magaldi has also participated in the U.S. Department of State's Virtual Student Foreign Service Intern Program. As virtual intern, Dr. Magaldi collaborated with the U.S. embassy in Mongolia to help facilitate science and technology collaborations between the U.S. and Mongolia. In particular, Dr. Magaldi researched ways in which the United States could assist Mongolia in bolstering STEM education at the college and graduate level.


Finally, Dr. Magaldi was an Executive Board member for the Career Network for Science PhDs at Yale, an organization dedicated to improving career opportunities for science PhDs through networking and internship opportunities. In 2006, Dr. Magaldi graduated with honors from Providence College with a BS in Biology. Dr. Magaldi currently lives in Long Island with his wife and infant son.


LinkedIn Profile



William Marshall, JR., MD, MS, MBA

back to list

Dr. Marshall is the Vice-Chair for Finance and Administration, Department of Psychiatry and Professor, Departments of Surgery and Psychiatry at the University of South Florida Morsani College of Medicine (MCOM). He is Director of the Scholarly Concentration in Innovation, Entrepreneurship and Business at the MCOM and developed and manages the USF MCOM Business of Medicine / Healthcare Bootcamp, the Healthcare Innovation Competition, and USF Health Healthcare Business Externship Program.


Dr. Marshall is Associate Director for the Technology Entrepreneurship Program and the USF Center for Entrepreneurship where he teaches Ethics of Innovation & Technology, Principles of Intellectual Property, Fundamentals of Venture Capital and Private Equity, and Development of a Fundable Business in the award-winning USF Technology Entrepreneurship Masters Degree Program, which he co-developed. Dr. Marshall has taught in the award-winning Technology Entrepreneurship Masters Degree Program, in the Colleges of Medicine and Business, and in the USF Honors College over the last 10 years.



Rubin Pillay

back to list

Rubin Pillay is a medical futurist and the Daniel White Jordan Chair and the Executive Director of the Center for Health Systems Innovation in the Spears School of Business and Center for Health Sciences at Oklahoma State University. He is a Family Physician and Clinical Pharmacologist who holds a PhD in Business Administration, an MBA and an MSc in Health Management. Prior to taking up his current position, he headed up programs in Health Leadership (with a focus on Operational Excellence) at the McKenna School of Business, Economics and Government (Pennsylvania, USA) and the School of Business and Finance (Cape Town, South Africa). He has extensive international teaching and consulting experience and has published widely in the field of Strategic Health Leadership. His current work focusses on the role of Creativity, Innovation and Entrepreneurship in the transformation of health and healthcare. He is the first President of the International Society of Healthcare Entrepreneurship Education and Research (ISHEER) and a Harvard Advanced Leadership Fellow in Health Innovation. Apart from starting several successful biomedical ventures of his own, he has also invested in several others


LinkedIn Profile



Frank Portugal back to list

Frank Portugal (Columbia University, College of Pharmacy ’62) received his Ph.D. from the U. of Illinois and did his postdoctoral work at the National Institutes of Health with Dr. Marshall Nirenberg (Nobel Laureate, 1967).  He is currently Clinical Associate Professor of Biology and Director, M.S. in Biotechnology Program, at The Catholic University of America in Washington, D.C.  Dr. Portugal holds four issued patents for a molecular method for distinguishing the four main species of the human pathogen, Shigella, and for development of an electro-optical biosensor developed jointly with the Department of Electrical and Computer Engineering at the University of Maryland, College Park.  As Professor of Biotechnology at the University of Maryland University College, before assuming his current position, Dr. Portugal taught biotechnology and other science courses both online and in traditional classroom settings.


LinkedIn Profile



Brendan Rauw back to list

Brendan Rauw is Associate Vice Chancellor and Executive Director of Entrepreneurship at the University of California, Los Angeles (UCLA). He is responsible for leading the Office of Intellectual Property and Industry Sponsored Research, and overseeing a variety of programs designed to stimulate and encourage innovation, entrepreneurship, and transfer of intellectual property into real-world applications.


Previously, he held leadership positions at Columbia Technology Ventures, KAUST, and the Boston Consulting Group (BCG). He also worked in corporate and business development with Genzyme Corporation and Celator Pharmaceuticals, a private biopharmaceutical company.


He has an undergraduate degree with high honors in biology from Harvard College and an MBA from Harvard Business School, where he was a recipient of the McArthur Fellowship.


LinkedIn Profile



Randall Ribaudo, Ph.D. back to list

President, CEO Human Workflows, LLC, co-founder,


Human Workflows and SciPhD co-founder Dr. Randall Ribaudo has over twenty years of experience in the Scientific Research and biotechnology field and has successfully made the transition from academia to industry. Dr. Ribaudo co-founded Human Workflows after more than five years at Celera Genomics. During his time at Celera, Dr. Ribaudo has acted as a liaison between Celera and the pharmaceutical, biotechnology and academic communities, served as product manager responsible for developing support products for the Proteomics Groups mass spectrometry software, led the iScience Task Force to define strategic directions for sister company Applied Biosystems, advised on product development for the Celera Discovery System and enterprise solutions for information integration, and worked as a Manager of Strategic Solutions in the Informatics business.


Prior to Celera, Dr. Ribaudo worked at the biotechnology and bioinformatics company Molecular Applications Group. MAG developed pioneering bioinformatics solutions for molecular modeling, information integration, gene expression analysis, and protein function prediction. While at MAG, Dr. Ribaudo was responsible for presenting the revolutionary capabilities of MAG's products to representatives in the pharmaceutical, biotechnology and academic communities.  In 1999, when Celera Genomics acquired the Protein Function Prediction assets of Molecular Applications Group, Dr. Ribaudo joined their staff.


Dr. Ribaudo also has extensive experience in the academic biological life sciences arena as well. After receiving a Ph.D. in Immunology at the University of Connecticut, Dr. Ribaudo joined the Laboratory of Immunology, NIAID at the National Institutes of Health where he studied the molecular basis of antigen presentation. Dr. Ribaudo then accepted a position in the National Cancer Institute in the Laboratory of Immune Cell Biology as a Principal Investigator where he developed his own research program studying the immune response to viruses and tumors, leading a team of postdoctoral fellows, technicians, and University and High School students. His work at the National Cancer Institute led to the development of a novel technology to develop vaccines against tumors and viruses. Dr. Ribaudo holds patents for this technology which are now being further developed by private companies.


All of this experience has provided Dr. Ribaudo with tremendous insight into the rapidly exploding technological capabilities in areas of discovery research, information and data management, as well as a detailed understanding of the human workflows that are required to successfully implement those technological solutions.  This knowledge is the basis of the consulting services Human Workflows offers to biotechnology and pharmaceutical companies in order to improve their transitional research programs.


Through extensive interactions with successful scientists in industry settings, it became clear that there are important skillsets outside the scientific/technical skills that are essential to being competitive and successful in industry careers. The SciPhD training programs focus on teaching those skills to academic scientists in order to make them more competitive in industry positions.


LinkedIn Profile



Miguel Rojas-Chaves

back to list

I have a major in Microbiology and Clinical Chemistry from the University of Costa Rica, Faculty of Microbiology (September 1983). I got my Ph.D. in Natural Sciences from the University of Hamburg, Faculty of Biology and Bernhard-Nocht-Institute of Tropical Medicine, Hamburg, Germany (May 1994). I speak Spanish, German and English.


I am a professor at the Costan Rica Institute of Technology  (TEC). Since 1998 I have worked at the School of Biology (for the Biotechnological Engineering, B.Sc) with the following courses:

  • Biochemistry (theory and laboratory).
  • Applied Microbiology (theory and laboratory).
  • General Biology (laboratory).
  • Introduction to Biotechnology.


I have also coordinated the Biotechnology’s Program Professional Practice and have advised the Professional Practice of 35 biotechnology engineering students. In 2008 I was declared “Outstanding Teacher” of the School of Biology at TEC.


From 2008 to 2012 I was an academic member of the Research and Extension Council at TEC.


Currently I am the coordinator of the Biotechnological Research Center.


I also worked at the Universidad Latina De Costa Rica, Costa Rica National Biodiversity Institute, Veterinary School at the National University and the Cellular and Molecular Biology Research Center at University of Costa Rica.


I have collaborated in the formulation of the National Science and Technology Plan, Costa Rica (2011-2014).


I have been devoted to the research in the biochemistry of tropical parasites, active compounds bioprospection in Costa Rican’s biodiversity and production of biomaterials for treating skin pathologies. In this field, I received two awards (2008 and 2012) from the Pfizer Science Institute with projects developed at the Tissue Engineering Laboratory (TEC). I participated as a speaker in various forums in Latin America, USA, Europe and Asia. I have collaborated as a scientific project evaluator for the Costa Rica-USA Foundation and the National Center for Biotechnology Innovations of Costa Rica.


For several years, I have been very interested in finding financing options for micro enterprises developed by Biotechnology Engineering Alumni at a national and an international level. For this reason I am currently working in the establishment of joint projects between academia and private enterprises, in the field of biotechnology.


Finally, I am married to Ivette and we have two kids: Andrea and José Miguel.


LinkedIn Profile



David Sable, MD back to list

David Sable MD directs healthcare and life science investing for the Special Situations Funds and is portfolio manager of the Special Situations Life Sciences Fund. After graduating from the Wharton School and the University of Pennsylvania School of Medicine, he completed his residency in obstetrics and gynecology at New York Hospital - Cornell Medical Center, and a reproductive endocrinology fellowship at Brigham and Women's Hospital. He co-founded and served as director of the Institute for Reproductive Medicine and Science at Saint Barnabas Medical Center in New Jersey, and was founder and CEO of Assisted Reproductive Medical Technologies, a private company that was acquired in 1999.


After leaving clinical medicine at age 43, Dr. Sable managed a proprietary healthcare portfolio at Deutsche Bank before joining the Special Situations Funds. Dr. Sable is an adjunct in the department of biology at Columbia University, and teaches “Entrepreneurship in Biotechnology” at Columbia’s Graduate School of Arts and Sciences. He serves as a corporate director for Genenews, a Toronto-based diagnostics company and for Hamilton Thorne, a Massachusetts medical device company, and serves on the clinical advisory board for Ovascience, a biotechnology company. He has lectured on healthcare investing, policy, and biotechnology business development at the Wharton School, NYU, Rockefeller University and Rutgers; has delivered keynote addresses to the American Fertility Society, the Texas Fertility Society and the Mexican Fertility Society; and appeared on the CBS Morning News, ABC World News Tonight, NY1 News and PBS’ Nova. In addition to his academic publications, he has written for the Newark Star-Ledger, Yoga Journal, Xconomy, Genetic Engineering and Biotechnology News and the Columbia Spectator.


LinkedIn Profile



Emily Sheridan back to list
Emily Sheridan is a Senior Director of Business Development for Alexandria Real Estate Equities, Inc. Ms. Sheridan works primarily on the development, marketing, and programming of the collaborative spaces at the Alexandria Center for Life Science – New York City. Prior to joining Alexandria in 2010, Ms. Sheridan was a development officer at City of Hope, an NCI-designated Comprehensive Cancer Center in Duarte, CA, where she raised funds to advance the development of new, more effective therapies and cures for patients    , diabetes and other life-threatening diseases. Prior to that, Ms. Sheridan raised funds for the Bogart Pediatric Cancer Research Program, the west coast office of the T.J. Martell Foundation for leukemia, cancer and AIDS research. Ms. Sheridan has a B.A. in Psychology from Vassar College.



Lidia Sobkow back to list

Dr Sobkow has a M.S. in biotechnology from Warsaw University of Technology (Poland, 2001), PhD in Molecular Biology from Max Planck Institute for Cell Biology and Genetics (Dresden, Germany, 2006) and 5 years of a postdoctoral experience in fields of stem cells/tissue engineering and biochemistry, both in Germany and the US. In January 2012 Dr. Sobkow joined the Center for Biotechnology as a Technology Commercialization Fellow to support the bioscience business development and commercialization consulting programs designed to aid start-up company growth and transition of new life sciences technologies into the successful product. Her work involves project management for emerging bioscience corporate and academic clients, while overseeing student teams from the College of Business (SBU) and Fundamentals of Bioscience Program (CFB). Dr. Sobkow is an integral part of the FoBI program acting as a teaching assistant alongside industry experts; she is also alumni of CFB's Fundamentals of Bioscience Industry Program 2011.


LinkedIn Profile



Nathan Tinker back to list

Executive Director, NewYorkBIO


LinkedIn Profile



Finn Valentin back to list

Finn Valentin is professor at Copenhagen Business School where he directs its Research Centre on Biotech Business and heads its teaching platform on bio business, including its two year Master’s Degree in Bioentrepreneurship.


FV’s research is about science-based firms and innovations, particularly those in biotech. His publications in international journals study the role of IPR, venture capital, academic entrepreneurship, national and regional innovation systems etc. Current projects examine how the organization of academic research affects its contribution to technological innovation. His research is funded by The Social Science Research Council, The Danish Research Council, The Øresund Research Committee, Ministries of Research and Industry and from the EU.


Finn Valentin has been a Research Fellow with Harvard University (Fulbright Scholar) and the European University Institute, Florence. He has been Head of Department during his affiliations with both Copenhagen University and Copenhagen Business School. He served four years on the Social Science Research Council, including three years as its Vice Chairman. Recently he served two years as the Vice Chairman on the Academic Council at CBS. He has served on a number of advisory committees and boards including the Danish Building Research Institute, Risø National Laboratory, in the Ministry of Science, in the EU and UN.


LinkedIn Profile



Katherine Wellman back to list

Katherine Wellman is the coordinator for the Biotechnology Enterprise programs and a full time faculty member in the Center for Biotechnology Education. These programs include the Master of Biotechnology Enterprise and Entrepreneurship, the joint MS Biotechnology/MBA, the MS in Biotechnology concentration in biotechnology enterprise and the Certificate in Biotechnology Enterprise. Katherine brings extensive experience in various training, regulatory, operations, environmental, health and safety leadership positions in the pharmaceutical and life science business sectors domestically and internationally. She is a graduate of Johns Hopkins University, receiving her MS in Biotechnology from the Zanvyl Krieger School of Arts and Sciences and an MBA from the Carey Business School. She also earned an MS in Health and Safety from Indiana State University and a BS in Health and Safety, Biology and Public Health with an education emphasis from Ball State University. Katherine is a doctoral student at the School of Public and International Affairs at the University of Baltimore College of Public Affairs completing her dissertation on public participation and regulatory aspects of emerging technologies. Her research interests include governing science, corporate social responsibility and the exploration of enterprise and entrepreneurship in the life sciences.


LinkedIn Profile



Mitchell Wong back to list

Mitchell M. Wong is one of only several American litigators qualified to
practice law across three continents: he is admitted in New York, England and Wales, and Hong Kong. In addition, he is a licensed patent practitioner in both the United States and Canada.


Mr. Wong's practice focuses on complex commercial litigation and
intellectual property, with emphasis on biotechnology and drug
development. Mr. Wong has been responsible for numerous patent
matters in the federal courts and both inter partes and ex parte proceedings before the U.S. Patent & Trademark Office.


In 2008, the New York State Legislature called Mr. Wong to testify as an impartial witness on the role of pharmaceutical patents in the
commercialization of generic drugs. Additionally, Mr. Wong has been
quoted in the press on matters relating to patent litigation over
therapeutic drugs. He also lectures on patent and regulatory matters at professional conferences, and has authored technical articles about drug development in peer-reviewed publications.


Mr. Wong was educated at Columbia College, which he attended on a
Westinghouse Science Scholarship, and the Cornell Law School, where he was Managing Editor of the Cornell Law Review. Before entering practice, Mr. Wong served as a law clerk to the Honorable Andrew J. Kleinfeld of the U.S. Court of Appeals for the Ninth Circuit, and as a Law Intern to the Honorable Frank X. Altimari of the U.S. Court of Appeals for the Second Circuit.


Mr. Wong is a co-founder and current principal at the New York office of The Exeter Law Group LLP.


LinkedIn Profile







Webpage: Carol Lin; Photo: Dora Corbinik © 2013